Infliximab ELISA Kit (Remicade®) (ab237644)
Key features and details
- Sensitivity: 30 ng/ml
- Range: 0.1 µg/ml - 3 µg/ml
- Sample type: Plasma, Serum
- Detection method: Colorimetric
- Assay type: Quantitative
- Reacts with: Human
Overview
-
Product name
Infliximab ELISA Kit (Remicade®)
See all Infliximab kits -
Detection method
Colorimetric -
Precision
Intra-assay Sample n Mean SD CV% Overall Inter-assay Sample n Mean SD CV% Overall -
Sample type
Serum, Plasma -
Assay type
Quantitative -
Sensitivity
30 ng/ml -
Range
0.1 µg/ml - 3 µg/ml -
Recovery
Sample specific recovery Sample type Average % Range Serum 85% - 115% -
Assay duration
Multiple steps standard assay -
Species reactivity
Reacts with: Human -
Product overview
Infliximab ELISA Kit (Remicade®) (ab237644) is a highly specific and sensitive kit designed for the in vitro determination of Infliximab in biological matrices such as human serum and plasma. The density of color is proportional to the amount of Infliximab captured from the samples and can be quantified when compared with standard curve.
Infliximab (Remicade®) is a chimeric monoclonal antibody and used to treat auto-immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFα) in the body by binding to it and preventing it from signaling the receptors for TNFα on the surface of various cell types. TNFα is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis.
-
Platform
Microplate
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 96 tests Assay Buffer 1 x 50ml HRP-conjugate Probe 1 x 12ml Infliximab Standard S1 1 x 300µl Infliximab Standard S2 1 x 300µl Infliximab Standard S3 1 x 300µl Infliximab Standard S4 1 x 300µl Infliximab Standard S5 1 x 300µl Infliximab Standard S6 1 x 300µl Infliximab Standard S7 1 x 300µl Micro ELISA Plate 1 unit Plate sealers 2 units Stop Solution 1 x 12ml TMB substrate 1 x 12ml Wash buffer (20X) 1 x 50ml -
Relevance
Infliximab (Remicade®) is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. -
Alternative names
- human tumour necrosis factor alpha
- Remicade
Images
-
Example of Infliximab standard curve
Typical Standard Curve: This standard curve is for demonstration only. A standard curve must be run with each assay.
